264 related articles for article (PubMed ID: 26086792)
1. Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia or bipolar disorder: A randomised, placebo-controlled, blinded trial.
Baandrup L; Lindschou J; Winkel P; Gluud C; Glenthoj BY
World J Biol Psychiatry; 2016 Oct; 17(7):514-24. PubMed ID: 26086792
[TBL] [Abstract][Full Text] [Related]
2. Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo.
Baandrup L; Fagerlund B; Glenthoj B
Eur Arch Psychiatry Clin Neurosci; 2017 Mar; 267(2):163-171. PubMed ID: 27400927
[TBL] [Abstract][Full Text] [Related]
3. Objective and subjective sleep quality: Melatonin versus placebo add-on treatment in patients with schizophrenia or bipolar disorder withdrawing from long-term benzodiazepine use.
Baandrup L; Glenthøj BY; Jennum PJ
Psychiatry Res; 2016 Jun; 240():163-169. PubMed ID: 27107670
[TBL] [Abstract][Full Text] [Related]
4. Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial.
Baandrup L; Fasmer OB; Glenthøj BY; Jennum PJ
BMC Psychiatry; 2016 Oct; 16(1):348. PubMed ID: 27737649
[TBL] [Abstract][Full Text] [Related]
5. Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol.
Baandrup L; Fagerlund B; Jennum P; Lublin H; Hansen JL; Winkel P; Gluud C; Oranje B; Glenthoj BY
BMC Psychiatry; 2011 Oct; 11():160. PubMed ID: 21975110
[TBL] [Abstract][Full Text] [Related]
6. Facilitation of benzodiazepine discontinuation by melatonin: a new clinical approach.
Garfinkel D; Zisapel N; Wainstein J; Laudon M
Arch Intern Med; 1999 Nov; 159(20):2456-60. PubMed ID: 10665894
[TBL] [Abstract][Full Text] [Related]
7. A double blind-placebo controlled study on melatonin efficacy to reduce anxiolytic benzodiazepine use in the elderly.
Cardinali DP; Gvozdenovich E; Kaplan MR; Fainstein I; Shifis HA; Pérez Lloret S; Albornoz L; Negri A
Neuro Endocrinol Lett; 2002 Feb; 23(1):55-60. PubMed ID: 11880863
[TBL] [Abstract][Full Text] [Related]
8. Electroacupuncture for tapering off long-term benzodiazepine use: A randomized controlled trial.
Yeung WF; Chung KF; Zhang ZJ; Zhang SP; Chan WC; Ng RM; Chan CL; Ho LM; Yu BY; Chau JC; Lau NC; Lao LX
J Psychiatr Res; 2019 Feb; 109():59-67. PubMed ID: 30504097
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Melatonin on Benzodiazepine Discontinuation and Sleep Quality in Adults Attempting to Discontinue Benzodiazepines: A Systematic Review and Meta-Analysis.
Wright A; Diebold J; Otal J; Stoneman C; Wong J; Wallace C; Duffett M
Drugs Aging; 2015 Dec; 32(12):1009-18. PubMed ID: 26547856
[TBL] [Abstract][Full Text] [Related]
10. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
Mercier-Guyon C; Chabannes JP; Saviuc P
Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
[TBL] [Abstract][Full Text] [Related]
11. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
[TBL] [Abstract][Full Text] [Related]
12. [alpha-beta L-aspartate magnesium in treatment of chronic benzodiazepine abuse: controlled and double-blind study versus placebo].
Hantouche EG; Guelfi JD; Comet D
Encephale; 1998; 24(5):469-79. PubMed ID: 9850822
[TBL] [Abstract][Full Text] [Related]
13. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
Wade AG; Crawford G; Ford I; McConnachie A; Nir T; Laudon M; Zisapel N
Curr Med Res Opin; 2011 Jan; 27(1):87-98. PubMed ID: 21091391
[TBL] [Abstract][Full Text] [Related]
14. Withdrawal reaction after long-term therapeutic use of benzodiazepines.
Busto U; Sellers EM; Naranjo CA; Cappell H; Sanchez-Craig M; Sykora K
N Engl J Med; 1986 Oct; 315(14):854-9. PubMed ID: 3092053
[TBL] [Abstract][Full Text] [Related]
15. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
Lemoine P; Nir T; Laudon M; Zisapel N
J Sleep Res; 2007 Dec; 16(4):372-80. PubMed ID: 18036082
[TBL] [Abstract][Full Text] [Related]
16. Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial.
Romo-Nava F; Alvarez-Icaza González D; Fresán-Orellana A; Saracco Alvarez R; Becerra-Palars C; Moreno J; Ontiveros Uribe MP; Berlanga C; Heinze G; Buijs RM
Bipolar Disord; 2014 Jun; 16(4):410-21. PubMed ID: 24636483
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Melatonin Upon Postacute Withdrawal Among Males in a Residential Treatment Program (M-PAWS): A Randomized, Double-blind, Placebo-controlled Trial.
Bondi CD; Kamal KM; Johnson DA; Witt-Enderby PA; Giannetti VJ
J Addict Med; 2018; 12(3):201-206. PubMed ID: 29351138
[TBL] [Abstract][Full Text] [Related]
18. Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial.
Lähteenmäki R; Puustinen J; Vahlberg T; Lyles A; Neuvonen PJ; Partinen M; Räihä I; Kivelä SL
Br J Clin Pharmacol; 2014 Jun; 77(6):975-85. PubMed ID: 24286360
[TBL] [Abstract][Full Text] [Related]
19. Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone maintenance treatment: a double-blind randomized clinical trial.
Peles E; Hetzroni T; Bar-Hamburger R; Adelson M; Schreiber S
Addiction; 2007 Dec; 102(12):1947-53. PubMed ID: 17916225
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
Small GW; Bystritsky A
J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
